Skip to content
February 03, 2023

Equity.Guru

Investment information for the new generation

neutropenia

Spectrum Pharmaceuticals (SPPI.Q) announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company’s Biologics License Application (BLA)…